Q: Can I get your opinion on PBH earnings today as well as your expectations for growth going forwards. The stock is down significantly Is it a buy, sell or hold?
5i Research Answer:
EPS of $1.29 missed estimates of $1.31; revenue of $1.89B missed estimates of $1.91B. EBITDA of $179M matched estimates. Guidance was in range of estimates, but at the low end for sales: $9.25B to $9.55B vs estimates $9.47B. EBITDA guidance of $870M to $890M was in a similar range. EBITDA rose 21% in the quarter, with specialty foods the stand out. Revenue rose 16%. Not perfect numbers, certainly, but not a disaster. The 13x valuation of the company reflects uncertainty (costs, labour, economic). Consensus still calls for good growth in 2026 and 2027 overall. The conference call had not yet occurred at the time of this answer. HOLD.